StoryCommercial
Intuitive launches Ion in South Korea
Intuitive Surgical Korea introduced Ion, Intuitive's robotic lung-biopsy system and first non-surgical platform, making South Korea the fourth country to adopt it. Ion was installed at ~800 sites worldwide with >200,000 procedures done by end-2024.
- South Korea is fourth country to launch Ion (after US, Europe, Asia-Pacific); proof of multinational adoption.
- ~800 systems installed globally; >200,000 procedures (end-2024) show strong clinical uptake.
- Ion reaches outer lung where >70% of nodules form; thin catheter accesses peripheral lesions vs bronchoscopes.
- Expansion proves Ion as non-surgical robotics platform; opens market beyond da Vinci surgical ecosystem.